SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-036231
Filing Date
2024-08-08
Accepted
2024-08-08 17:06:14
Documents
90
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dna-20240630.htm   iXBRL 10-Q 1569529
2 EX-31.1 dna-20240630xex311.htm EX-31.1 11788
3 EX-31.2 dna-20240630xex312.htm EX-31.2 11805
4 EX-32.1 dna-20240630xex321.htm EX-32.1 5894
5 EX-32.2 dna-20240630xex322.htm EX-32.2 6006
  Complete submission text file 0001628280-24-036231.txt   8979285

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20240630.xsd EX-101.SCH 56702
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dna-20240630_cal.xml EX-101.CAL 80345
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20240630_def.xml EX-101.DEF 373063
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20240630_lab.xml EX-101.LAB 678165
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20240630_pre.xml EX-101.PRE 551371
93 EXTRACTED XBRL INSTANCE DOCUMENT dna-20240630_htm.xml XML 1475218
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40097 | Film No.: 241189521
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)